Get started
Author

Luca Scafuri

Observed names: L. Scafuri, L., Scafuri
ORCID: 0000-0002-7410-8300
Observed ORCID: 0000-0002-7410-8300
OpenAlex ID: A5085376563
Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature
2021 · Felice Crocetto, Erika di Zazzo, et al. · Nutrients · 73
PDF
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor
2019 · M. Ferro, G. Di Lorenzo, et al. · World Journal of Urology · 58
PDF
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis
2020 · Carlo Buonerba, Matteo Ferro, et al. · Critical Reviews in Oncology/Hematology · 55
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review
2022 · Biagio Barone, Armando Calogero, et al. · Cancers · 53
PDF
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings
2020 · Matteo Ferro, Giuseppe Lucarelli, et al. · Critical Reviews in Oncology/Hematology · 52
Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
2020 · Carlo Buonerba, Pasquale Dolce, et al. · Cancers · 46
PDF
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial
2018 · Carlo Buonerba, Pietro De Placido, et al. · Frontiers in Pharmacology · 37
PDF
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone
2023 · Felice Crocetto, Matteo Ferro, et al. · Critical Reviews in Oncology/Hematology · 36
Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis
2019 · Carlo Buonerba, Simona Iaccarino, et al. · Cancers · 24
PDF
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
2021 · Giuseppe Di Lorenzo, Silvia Zappavigna, et al. · Clinical Genitourinary Cancer · 23
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis
2021 · Matteo Ferro, Ottavio de Cobelli, et al. · Frontiers in Oncology · 17
PDF
Impact of Dietary Supplements on Clinical Outcomes and Quality of Life in Patients with Breast Cancer: A Systematic Review
2025 · Luca Scafuri, Carlo Buonerba, et al. · Nutrients · 15
Gender minorities in breast cancer – Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients
2024 · Federica Miglietta, Letizia Pontolillo, et al. · The Breast · 10
PDF
Fisetin As an Adjuvant Treatment in Prostate Cancer Patients Receiving androgen-deprivation Therapy
2022 · Giuseppe Di Lorenzo, Luca Scafuri, et al. · Future Science OA · 10
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis
2023 · Matteo Ferro, Felice Crocetto, et al. · Clinical Genitourinary Cancer · 9
Study on the Impact of Hormone Therapy for Prostate Cancer on the Quality of Life and the Psycho-Relational Sphere of Patients: ProQoL
2024 · Francesca Cappuccio, Carlo Buonerba, et al. · Oncology and Therapy · 8
The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial
2022 · Giuseppe Di Lorenzo, Concetta Ingenito, et al. · Oncology · 8
PDF
COVID-19 and Prostate Cancer: a Complex Scenario With Multiple Facets
2021 · Felice Crocetto, Luciana Buonerba, et al. · Future Science OA · 8
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond
2024 · Carlo Buonerba, Concetta Ingenito, et al. · Oncology and Therapy · 7
PDF
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario
2023 · Giuseppe Di Lorenzo, Aieta Michele, et al. · Oncology and Therapy · 7
PDF
Mediterranean Diet as a Supportive Intervention in Cancer Patients: Current Evidence and Future Directions
2022 · Roberta Rubino, Michela Rosaria Iuliucci, et al. · Current Oncology · 6
PDF
A Risk-Group Classification Model in Patients with Bladder Cancer Under Neoadjuvant Cisplatin-Based Combination Chemotherapy
2021 · Matteo Ferro, Giuseppe Lucarelli, et al. · Future Oncology · 6
The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer
2017 · Carlo Buonerba, Guru Sonpavde, et al. · Journal of Cancer · 6
PDF
The Development and Initial Validation of the REST Questionnaire: A Multidimensional Tool for Assessing Fatigue in Individuals with and Without a History of Cancer
2025 · Giuseppe Di Lorenzo, Carlo Buonerba, et al. · Diseases · 5
PDF
The Impact of Flavonoid Supplementation on Serum Oxidative Stress Levels Measured via D-ROMs Test in the General Population: The PREVES-FLAVON Retrospective Observational Study
2024 · Giuseppe Di Lorenzo, Antonio Verde, et al. · Nutrients · 5
PDF
Works count: 51
Citation count: 631
H-index: 12
I10-index: 14
Year
Topic
Type